Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 May;66(5):700-3.
doi: 10.1136/ard.2006.060772. Epub 2006 Oct 13.

Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

Frédéric Lavie  1 , Corinne Miceli-Richard, Marc Ittah, Jérémie Sellam, Jacques-Eric Gottenberg, Xavier Mariette
Affiliations

Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

Frédéric Lavie et al. Ann Rheum Dis. 2007 May.

Abstract

Background: The cytokine B cell-activating factor of the TNF family (BAFF) is involved in the pathogenesis of autoimmune diseases.

Objective: To access changes in serum protein and mRNA levels of BAFF after rituximab treatment.

Methods: Serum and peripheral blood mononuclear cells (PBMCs) were isolated from five patients (two with lupus, two with Sjögren's syndrome, one with rheumatoid arthritis) before and 12 weeks (range 7-17) after a first course of rituximab infusion. Monocytes and B cells were selected from healthy controls and cocultured for 72 h. BAFF protein and mRNA levels were assessed by ELISA and real-time PCR, respectively.

Results: After rituximab treatment, median serum BAFF protein level and BAFF to actin mRNA ratio in PBMCs significantly increased. In monocytes cocultured with autologous B cells, BAFF protein level decreased, whereas the mRNA level was stable. In one closely monitored patient, the mRNA ratio of BAFF to actin in PBMCs increased later than the BAFF serum level.

Conclusions: Two distinct mechanisms are probably involved in the increase in BAFF level after B cell depletion: (1) the decrease in its receptors leading to a release of BAFF; (2) a delayed regulation of BAFF mRNA transcription. This could favour the re-emergence of autoreactive B cells.

PubMed Disclaimer

References

    1. Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 200517282–289. - PubMed
    1. Nardelli B, Belvedere O, Roschke V, Moore P A, Olsen H S, Migone T S.et al Synthesis and release of B‐lymphocyte stimulator from myeloid cells. Blood 200197198–204. - PubMed
    1. Ng L G, Sutherland A P, Newton R, Qian F, Cachero T G, Scott M L.et al B cell‐activating factor belonging to the TNF family (BAFF)‐R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 2004173807–817. - PubMed
    1. Mackay F, Sierro F, Grey S T, Gordon T P. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun 20058243–265. - PubMed
    1. Batten M, Fletcher C, Ng L G, Groom J, Wheway J, Laabi Y.et al TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol 2004172812–822. - PubMed

Publication types

MeSH terms